Patents

Dermala’s Patent Covers Use of Human Microbiome Technology for Treating Acne Vulgaris

Company also wins Cosmo's "Best Moisturizer" in 2021 Holy Grail Acne Awards.

Author Image

By: Christine Esposito

Editor-in-Chief

US Patent No. 11,154,522; Dermala has been awarded a patent for compositions and methods for treating acne vulgaris.This is the second patent in the company’s intellectual property portfolio that covers using the human microbiome to treat and prevent acne. The company developed a novel technology for enhanced targeted delivery of human microbiome-derived postbiotic metabolites into specific layers of the skin. This results in higher treatment efficacy due to targeted inhibition of C. acnes in fo...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters